Eiman Elwakeel
Impact in
- Immunology top 10%
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immune cells in cancer 3
- Phagocytosis and Immune Regulation 2
-
- Berberine and alkaloids research 2
- Cannabis and Cannabinoid Research 1
- Co-authors
- Andreas Weigert (8 shared papers)Bernhard Brüne (6 shared papers)Tobias Schmid (2 shared papers)Ryuichi Murase (1 shared paper)Sean D. McAllister (1 shared paper)Rumi Kawamura (1 shared paper)Anu Mahadevan (1 shared paper)Arash Pakdel (1 shared paper)
- Journals
- International Journal of Molecular Sciences (2 papers)The Journal of Experimental Medicine (1 paper)Prostaglandins & Other Lipid Mediators (1 paper)Oncogene (1 paper)Evidence-based Complementary and Alternative Medicine (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Eiman Elwakeel
14 papers receiving 895 citations
Eiman Elwakeel's Hit Papers
Peers
Comparison fields: 5 of 74
- Immunology 326
- Oncology 309
- Cancer Research 97
- Pharmacology 104
- Dermatology 43
Countries citing papers authored by Eiman Elwakeel
This map shows the geographic impact of Eiman Elwakeel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiman Elwakeel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiman Elwakeel more than expected).
Fields of papers citing papers by Eiman Elwakeel
This network shows the impact of papers produced by Eiman Elwakeel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiman Elwakeel. The network helps show where Eiman Elwakeel may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiman Elwakeel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer Hit paper breakdown → | 2022 | 266 |
| 2 | 2017 | 239 | |
| 3 | 2019 | 83 | |
| 4 | 2014 | 76 | |
| 5 | 2021 | 42 | |
| 6 | 2021 | 35 | |
| 7 | 2019 | 31 | |
| 8 | 2015 | 30 | |
| 9 | 2019 | 24 | |
| 10 | 2021 | 21 | |
| 11 | 2019 | 19 | |
| 12 | 2022 | 17 | |
| 13 | 2020 | 11 | |
| 14 | 2016 | 8 | |
| 15 | 2026 | 1 |
About Eiman Elwakeel
Eiman Elwakeel is a scholar working on Immunology, Pharmacology, Oncology, Molecular Biology and Biochemistry, having authored 15 papers that have together received 903 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (3 papers), Immune cells in cancer (3 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (2 papers), Berberine and alkaloids research (2 papers), Inflammasome and immune disorders (2 papers), Phagocytosis and Immune Regulation (2 papers) and Cannabis and Cannabinoid Research (1 paper). The work is most often cited by research in Immunology (326 citations), Oncology (309 citations), Cancer Research (97 citations), Pharmacology (104 citations) and Dermatology (43 citations). Eiman Elwakeel has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Andreas Weigert, Bernhard Brüne, Tobias Schmid, Ryuichi Murase, Sean D. McAllister, Rumi Kawamura, Anu Mahadevan, Arash Pakdel, Doaa Ahmad Ghareeb and Maha El Demellawy. Their work appears in journals such as International Journal of Molecular Sciences, The Journal of Experimental Medicine, Prostaglandins & Other Lipid Mediators, Oncogene and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.